{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:21:54Z","timestamp":1766049714009,"version":"3.48.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-025-00521-4","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:19:25Z","timestamp":1766049565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional characterization of splice variants in hereditary breast and ovarian cancer susceptibility genes"],"prefix":"10.1007","volume":"25","author":[{"given":"Laura","family":"Rosado-Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Younes","family":"Mestre-Terkemani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngeles","family":"Garc\u00eda-Aliaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda D.","family":"Sarabia-Meseguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Mar\u00edn-Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Mac\u00edas-Cerrolaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"S\u00e1nchez-Henarejos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda R.","family":"Garc\u00eda-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Zafra-Poves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz C.","family":"\u00c1lvarez-Abril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen B.","family":"L\u00f3pez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda P.","family":"Moya-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Pascual-Gilabert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Cer\u00f3n-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Castillo-Guardiola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ant\u00f3n-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Ayala-de la Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 L.","family":"Alonso-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Noguera-Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Ruiz-Espejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"issue":"3","key":"521_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13353-018-0444-7","volume":"59","author":"A Abramowicz","year":"2018","unstructured":"Abramowicz A, Gos M (2018) Splicing mutations in human genetic disorders: examples, detection, and confirmation. J Appl Genet 59(3):253\u2013268. https:\/\/doi.org\/10.1007\/s13353-018-0444-7","journal-title":"J Appl Genet"},{"issue":"10","key":"521_CR41","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1158\/2159-8290.CD-12-0189","volume":"2","author":"N Agrawal","year":"2012","unstructured":"Agrawal N, Jiao Y, Bettegowda C, Hutfless SM, Wang Y, David S et al (2012) Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov 2(10):899\u2013905. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0189","journal-title":"Cancer Discov"},{"issue":"3","key":"521_CR28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10689-017-0020-z","volume":"17","author":"J Azzollini","year":"2018","unstructured":"Azzollini J, Mariani M, Peissel B, Manoukian S (2018) Increased access to TP53 analysis through breast cancer multi-gene panels: clinical considerations. Fam Cancer 17(3):317\u2013319. https:\/\/doi.org\/10.1007\/s10689-017-0020-z","journal-title":"Fam Cancer"},{"issue":"5","key":"521_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1042\/CS20160211","volume":"131","author":"D Baralle","year":"2017","unstructured":"Baralle D, Buratti E (2017) RNA splicing in human disease and in the clinic. Clin Sci 131(5):355\u2013368. https:\/\/doi.org\/10.1042\/CS20160211","journal-title":"Clin Sci"},{"issue":"2","key":"521_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10549-014-3011-x","volume":"146","author":"K Bell","year":"2014","unstructured":"Bell K, Hodgson N, Levine M, Sadikovic B, Zbuk K (2014) Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer. Breast Cancer Res Treat 146(2):447\u2013450. https:\/\/doi.org\/10.1007\/s10549-014-3011-x","journal-title":"Breast Cancer Res Treat"},{"key":"521_CR43","doi-asserted-by":"publisher","first-page":"102522","DOI":"10.1016\/j.ctrv.2023.102522","volume":"114","author":"E Blondeaux","year":"2023","unstructured":"Blondeaux E, Arecco L, Punie K, Graffeo R, Toss A, De Angelis C et al (2023) Germline TP53 pathogenic variants and breast cancer: a narrative review. Cancer Treat Rev 114:102522. https:\/\/doi.org\/10.1016\/j.ctrv.2023.102522","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"521_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"521_CR19","unstructured":"ClinGen Variant Classification Guidance Clinical Genome Resource. Available online: https:\/\/www.clinicalgenome.org\/tools\/clingen-variant-classification-guidance\/"},{"key":"521_CR9","unstructured":"Daly MB, Pilarski R, Berry MP, Buys SS, Friedman S, Garber JE et al (2019) NCCN Clinical Practice Guidelines in Oncology. Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic. J Natl Compr Canc Netw Version 3"},{"issue":"43W1","key":"521_CR21","doi-asserted-by":"publisher","first-page":"W389","DOI":"10.1093\/nar\/gkv332","volume":"1","author":"A Drozdetskiy","year":"2015","unstructured":"Drozdetskiy A, Cole C, Procter J, Barton GJ (2015) JPred4: a protein secondary structure prediction server. Nucleic Acids Res 1(43W1):W389\u2013W394. https:\/\/doi.org\/10.1093\/nar\/gkv332","journal-title":"Nucleic Acids Res"},{"key":"521_CR6","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1093\/annonc\/mdv278","volume":"26","author":"DM Eccles","year":"2015","unstructured":"Eccles DM, Mitchell G, Monteiro AN, Schmutzler R, Couch FJ, Spurdle AB et al (2015) BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance. Ann Oncol 26:2057\u20132065. https:\/\/doi.org\/10.1093\/annonc\/mdv278","journal-title":"Ann Oncol"},{"key":"521_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2014.10.008","volume":"41","author":"P Economopoulou","year":"2015","unstructured":"Economopoulou P, Dimitriadis G, Psyrri A (2015) Beyond BRCA: new hereditary breast cancer susceptibility genes. Cancer Treat Rev 41:1\u20138. https:\/\/doi.org\/10.1016\/j.ctrv.2014.10.008","journal-title":"Cancer Treat Rev"},{"key":"521_CR2","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L et al (2022) Global Cancer Observatory: cancer today. International Agency for Research on Cancer. Available online: https:\/\/gco.iarc.fr\/"},{"issue":"3","key":"521_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/humu.24152","volume":"42","author":"C Fortuno","year":"2021","unstructured":"Fortuno C, Lee K, Olivier M, Pesaran T, Mai PL, de Andrade KC (2021) ClinGen TP53 variant curation expert Panel. Specifications of the ACMG\/AMP variant interpretation guidelines for germline TP53 variants. Hum Mutat 42(3):223\u2013236. https:\/\/doi.org\/10.1002\/humu.24152","journal-title":"Hum Mutat"},{"issue":"3","key":"521_CR26","first-page":"608","volume":"56","author":"T Frebourg","year":"1995","unstructured":"Frebourg T, Barbier N, Yan YX, Garber JE, Dreyfus M, Fraumeni J Jr et al (1995) Germline p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet 56(3):608\u2013615 PMID: 7887414","journal-title":"Am J Hum Genet"},{"issue":"1","key":"521_CR39","first-page":"3","volume":"20","author":"M Georgieva","year":"2008","unstructured":"Georgieva M, Krasteva M, Angelova E, Ralchev K, Dimitrov V, Bozhimirov S et al (2008) Analysis of the K-ras\/B-raf\/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients. Oncol Rep 20(1):3\u201311 PMID: 18575712","journal-title":"Oncol Rep"},{"key":"521_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/path.2784","volume":"223","author":"A Goh","year":"2011","unstructured":"Goh A, Coffill C, Lane D (2011) The role of mutant p53 in human cancer. J Pathol 223:116\u2013126. https:\/\/doi.org\/10.1002\/path.2784","journal-title":"J Pathol"},{"issue":"2","key":"521_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12094-019-02262-0","volume":"22","author":"S Gonz\u00e1lez-Santiago","year":"2020","unstructured":"Gonz\u00e1lez-Santiago S, Ram\u00f3n y Cajal T, Aguirre E, Al\u00e9s-Mart\u00ednez JE, Andr\u00e9s R, Balma\u00f1a J et al (2020) SEOM clinical guidelines in hereditary breast and ovarian cancer (2019). Clin Transl Oncol 22(2):193\u2013200. https:\/\/doi.org\/10.1007\/s12094-019-02262-0","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"521_CR34","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s10549-012-2050-4","volume":"134","author":"S Heidemann","year":"2012","unstructured":"Heidemann S, Fischer C, Engel C, Fischer B, Harder L, Schlegelberger B et al (2012) Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management. Breast Cancer Res Treat 134(3):1229\u20131239. https:\/\/doi.org\/10.1007\/s10549-012-2050-4","journal-title":"Breast Cancer Res Treat"},{"key":"521_CR35","doi-asserted-by":"publisher","unstructured":"Hoang LN, Gilks BC (2018) Hereditary Breast and Ovarian Cancer Syndrome: moving beyond BRCA1 and BRCA2. Adv Anat Pathol 25(2):85\u201395. https:\/\/doi.org\/10.1097\/PAP.0000000000000177","DOI":"10.1097\/PAP.0000000000000177"},{"key":"521_CR15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI et al (2019) Predicting splicing from primary sequence with deep learning. Cell 176:535\u2013548e24. https:\/\/doi.org\/10.1016\/j.cell.2018.12.015","journal-title":"Cell"},{"issue":"3","key":"521_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13167-010-0037-y","volume":"1","author":"R Janavi\u010dius","year":"2010","unstructured":"Janavi\u010dius R (2010) Founder BRCA1\/2 mutations in the europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J 1(3):397\u2013412. https:\/\/doi.org\/10.1007\/s13167-010-0037-y","journal-title":"EPMA J"},{"key":"521_CR17","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","volume":"35","author":"C Kopanos","year":"2019","unstructured":"Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca M, Meyer R et al (2019) VarSome: the human genomic variant search engine. Bioinformatics 35:1978\u20131980. https:\/\/doi.org\/10.1093\/bioinformatics\/bty897","journal-title":"Bioinformatics"},{"key":"521_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13104-017-2511-2","volume":"10","author":"FZ Laarabi","year":"2017","unstructured":"Laarabi FZ, Ratbi I, Elalaoui SC, Mezzouar L, Doubaj Y, Bouguenouch L et al (2017) High frequency of the recurrent c.1310_1313delAAGA BRCA2 mutation in the North-East of Morocco and implication for hereditary breast\u2013ovarian cancer prevention and control. BMC Res Notes 10:188. https:\/\/doi.org\/10.1186\/s13104-017-2511-2","journal-title":"BMC Res Notes"},{"key":"521_CR29","doi-asserted-by":"publisher","unstructured":"Laraqui A, Uhrhammer N, Rhaffouli H, Sekhsokh Y, Lahlou-Amine I, Bajjou T et al (2015) BRCA genetic screening in middle Eastern and North african: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African. Dis Markers 2015(194293). https:\/\/doi.org\/10.1155\/2015\/194293","DOI":"10.1155\/2015\/194293"},{"key":"521_CR3","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/s12094-015-1435-3","volume":"17","author":"G Llort","year":"2015","unstructured":"Llort G, Chirivella I, Morales R, Serrano R, Sanchez AB, Teul\u00e9 A et al (2015) SEOM clinical guidelines in hereditary breast and ovarian cancer. Clin Transl Oncol 17:956\u2013961. https:\/\/doi.org\/10.1007\/s12094-015-1435-3","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"521_CR36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","volume":"21","author":"N Mavaddat","year":"2012","unstructured":"Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H et al (2012) Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1\/2 (CIMBA). Cancer Epidemiol Biomark Prev 21(1):134\u2013147. https:\/\/doi.org\/10.1158\/1055-9965.EPI-11-0775","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"521_CR23","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/humu.23583","volume":"39","author":"G Montalban","year":"2018","unstructured":"Montalban G, Fraile-Bethencourt E, L\u00f3pez-Perolio I, P\u00e9rez-Segura P, Infante M, Dur\u00e1n M et al (2018) Characterization of spliceogenic variants located in regions linked to high levels of alternative splicing: BRCA2 c.7976\u2009+\u20095G\u2009>\u2009T as a case study. Hum Mutat 39(9):1155\u20131160. https:\/\/doi.org\/10.1002\/humu.23583","journal-title":"Hum Mutat"},{"key":"521_CR11","unstructured":"NCBI, ClinVar Available online: https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/VCV000037698.69"},{"key":"521_CR12","unstructured":"NCBI, ClinVar Available online: https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/VCV000634838.2"},{"key":"521_CR13","unstructured":"NCBI, ClinVar Available online: https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/VCV000439316.12"},{"key":"521_CR14","unstructured":"NCBI, ClinVar Available online: https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/VCV000279766.39"},{"issue":"9","key":"521_CR33","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.ajhg.2024.07.013","volume":"5","author":"MT Parsons","year":"2024","unstructured":"Parsons MT, de la Hoya M, Richardson ME, Tudini E, Anderson M, Berkofsky-Fessler W (2024) Evidence-based recommendations for gene-specific ACMG\/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 variant curation expert panel. Am J Hum Genet 5(9):2044\u20132058. https:\/\/doi.org\/10.1016\/j.ajhg.2024.07.013","journal-title":"Am J Hum Genet"},{"key":"521_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"issue":"3","key":"521_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/mps4030062","volume":"4","author":"G Riolo","year":"2021","unstructured":"Riolo G, Cantara S, Ricci C (2021) What\u2019s wrong in a jump? Prediction and validation of splice site variants. Methods Protoc 4(3):62. https:\/\/doi.org\/10.3390\/mps4030062","journal-title":"Methods Protoc"},{"issue":"3","key":"521_CR42","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1158\/1078-0432.CCR-13-3310","volume":"21","author":"TY Seiwert","year":"2015","unstructured":"Seiwert TY, Zuo Z, Keck MK, Khattri A, Pedamallu CS, Stricker T et al (2015) Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res 21(3):632\u2013641. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-3310","journal-title":"Clin Cancer Res"},{"issue":"5","key":"521_CR40","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1016\/j.ajpath.2011.01.021","volume":"178","author":"I Soubeyran","year":"2011","unstructured":"Soubeyran I, Mahouche I, Grigoletto A, Leste-Lasserre T, Drutel G, Rey C et al (2011) Tissue microarray cytometry reveals positive impact of homeodomain interacting protein kinase 2 in colon cancer survival irrespective of p53 function. Am J Pathol 178(5):1986\u20131998. https:\/\/doi.org\/10.1016\/j.ajpath.2011.01.021","journal-title":"Am J Pathol"},{"key":"521_CR10","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","volume":"139","author":"PD Stenson","year":"2020","unstructured":"Stenson PD, Mort M, Ball EV, Chapman M, Evans K, Azevedo L et al (2020) The human gene mutation database (HGMD\u00ae): optimizing its use in a clinical diagnostic or research setting. Hum Genet 139:1197\u20131207. https:\/\/doi.org\/10.1007\/s00439-020-02199-3","journal-title":"Hum Genet"},{"issue":"3","key":"521_CR32","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.ygyno.2012.03.007","volume":"125","author":"A Tazzite","year":"2012","unstructured":"Tazzite A, Jouhadi H, Nadifi S, Aretini P, Falaschi E, Collavoli A et al (2012) BRCA1 and BRCA2 germline mutations in Moroccan breast\/ovarian cancer families: novel mutations and unclassified variants. Gynecol Oncol 125(3):687\u2013692. https:\/\/doi.org\/10.1016\/j.ygyno.2012.03.007","journal-title":"Gynecol Oncol"},{"key":"521_CR4","doi-asserted-by":"publisher","unstructured":"Toss A, Tomasello C, Razzaboni E, Contu G, Grandi G, Cagnacci A et al (2015) Hereditary ovarian cancer: not only BRCA1 and 2 genes. BioMed Res Int 2015(341723). https:\/\/doi.org\/10.1155\/2015\/341723","DOI":"10.1155\/2015\/341723"},{"issue":"1","key":"521_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.29010","volume":"121","author":"N Tung","year":"2015","unstructured":"Tung N, Battelli C, Allen B, Kaldate R, Bhatnagar S, Bowles K et al (2015) Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25 gene panel. Cancer 121(1):25\u201333. https:\/\/doi.org\/10.1002\/cncr.29010","journal-title":"Cancer"},{"issue":"7","key":"521_CR16","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ajhg.2023.06.002","volume":"6","author":"LC Walker","year":"2023","unstructured":"Walker LC, Hoya M, Wiggins GAR, Lindy A, Vincent LM, Parsons MT et al (2023) ClinGen sequence variant interpretation working group. Using the ACMG\/AMP framework to capture evidence related to predicted and observed impact on splicing: recommendations from the ClinGen SVI splicing subgroup. Am J Hum Genet 6(7):1046\u20131067. https:\/\/doi.org\/10.1016\/j.ajhg.2023.06.002","journal-title":"Am J Hum Genet"},{"issue":"2","key":"521_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1373\/clinchem.2013.210658","volume":"60","author":"PJ Whiley","year":"2014","unstructured":"Whiley PJ, de la Hoya M, Thomassen M, Becker A, Brand\u00e3o R, Pedersen IS et al (2014) ENIGMA consortium. Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing. Clin Chem 60(2):341\u2013352. https:\/\/doi.org\/10.1373\/clinchem.2013.210658","journal-title":"Clin Chem"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00521-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-025-00521-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00521-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:19:30Z","timestamp":1766049570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-025-00521-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["521"],"URL":"https:\/\/doi.org\/10.1007\/s10689-025-00521-4","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All participants provided written informed consent to be involved in the study and to authorize publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Clinical Universitary Hospital Virgen de la Arrixaca, Murcia, Spain. (protocol code 2021-6-9-HCUVA with approval date of 29 June 2021).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"5"}}